|
|
 |
|
Viewing report
|
|
|
|
bioMerieux SA - SWOT Analysis
MarketLine, July 2011, Pages: 22
bioMerieux SA - SWOT Analysis company profile is the essential source for top-level company data and information. bioMerieux SA - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
bioMerieux is a part of the Institut Merieux group. The company is engaged in providing in-vitro diagnostics for medical and industrial applications. It operates in EMEA (Europe, Middle East and Africa), North America, Asia-Pacific and Latin America. The company is headquartered in Marcy l'Etoile, France and employed 6,306 people as of December 2010. The company recorded revenues of E1,357 million (approximately $1,800.3 million) during the financial year ended December 2010 (FY2010), an increase of 10.9% over FY2009. The operating profit of the company was E244 million (approximately $323.7 million) during FY2010, an increase of 12.8% over FY2009. The net profit was E158.7 million (approximately $210.5 million) in FY2010, an increase of 7.4% over FY2009.
Scope of the Report
- Provides all the crucial information on bioMerieux SA required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting bioMerieux SA in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of bioMerieux SA
-Data is supplemented with details on bioMerieux SA history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from bioMerieux SA
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
